The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study
- PMID: 32927194
- PMCID: PMC10959283
- DOI: 10.1016/j.drugalcdep.2020.108248
The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study
Abstract
Background: Opioid prescribing guidelines recommend reducing or discontinuing opioids for chronic pain if harms of opioid treatment outweigh benefits. As opioid discontinuation becomes more prevalent, it is important to understand whether opioid discontinuation is associated with heroin use. In this study, we sought to assess the association between opioid discontinuation and heroin use documented in the medical record.
Methods: A matched nested case-control study was conducted in an integrated health plan and delivery system in Colorado. Patients receiving opioid therapy in the study period (January 2006-June 2018) were included. Opioid discontinuation was defined as ≥45 days with no opioids dispensed after initiating opioid therapy. The heroin use onset date represented the index date. Case patients were matched to up to 20 randomly selected patients without heroin use (control patients) by age, sex, calendar time, and time between initiating opioid therapy and the index date. Conditional logistic regression models estimated matched odds ratios (mOR) for the association between an opioid discontinuation prior to the index date and heroin use.
Results: Among 22,962 patients prescribed opioid therapy, 125 patients (0.54%) used heroin after initiating opioid therapy, of which 74 met criteria for inclusion in the analysis. The odds of opioid discontinuation were approximately two times higher in case patients (n = 74) than control patients (n = 1045; mOR = 2.19; 95% CI 1.27-3.78).
Conclusions: Among patients prescribed chronic opioid therapy, the observed increased risk for heroin use associated with opioid discontinuation should be balanced with potential benefits.
Keywords: Opioid discontinuation; heroin use; prescription opioid use.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declarations of interest
None
Figures
References
-
- Berna C, Kulich RJ, Rathmell JP, 2015. Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice. Mayo. Clin. Proc 90, 828–842. - PubMed
-
- Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C, 1985. Estimating the population attributable risk for multiple risk factors using case-control data. Am. J. Epidemiol 122, 904–914. - PubMed
-
- Centers for Disease Control and Prevention, 2011. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR. Morb. Mortal. Wkly. Rep 60, 1487. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
